<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">_____________________________</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>CURRENT REPORT<BR>
PURSUANT TO SECTION 13 OR 15(d) OF THE<BR>
SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Date of Report:</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">(Date of earliest event reported)</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>May 14, 2014</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>____________________________</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>DigiPath, Inc.</U></B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 0.25in; text-align: center">(Exact name of registrant as
specified in charter)</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Nevada</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">(State or other Jurisdiction of
Incorporation or Organization)</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; padding-right: 6pt; padding-left: 6pt">
        <P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>000-54239</U></B></P>
        <P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 2.9pt; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="width: 43%; padding-right: 6pt; padding-left: 6pt; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 26%; padding-right: 6pt; padding-left: 6pt">
        <P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 2.9pt; text-align: center"><B><U>27-3601979</U></B></P>
        <P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 2.9pt; text-align: center">(IRS Employer Identification
        No.)</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 2.9pt; text-align: center">28720 Roadside Drive, Suite 128</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 2.9pt; word-spacing: 0px; text-align: center"><U>Agoura Hills,
        CA 91301</U></P>
        <P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 2.9pt; text-align: center">(Address of Principal Executive
        Offices and zip code)</P></TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(702) 527-2060</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">(Registrant&rsquo;s telephone<BR>
number, including area code)</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">(Former name or former address,
if changed since last report.)</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">[ ] Soliciting material pursuant to Rule 14a-12(b) under
the Exchange Act (17 CFR 240.14a-12(b))</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt">[ ] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 3.02 Unregistered Sales of Equity
Securities.</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 14, 2014,
DigiPath, Inc. (the &ldquo;Company&rdquo;) completed a private placement offering to certain accredited investors (&ldquo;Investors&rdquo;)
pursuant to which the Company sold an aggregate of 44,200,000 shares of the Company&rsquo;s common stock (&ldquo;Shares&rdquo;)
resulting in gross proceeds of $2,210,000 to the Company. The Company intends to use proceeds of the offering for working capital
and to develop its new lines of business associated with the research, development, licensing and operation of botanical and nutra-pharmaceutical
products and services, including, without limitation, the licensing of brand name nutra-pharmaceutical products. These business
lines will supplement its existing digital pathology solutions business that continues to generate revenue. The Company has no
material relationship with any of the accredited investors participating in the private placement offering other than in respect
of the investments.</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The issuance of
the shares of the Company&rsquo;s common stock to the Investors pursuant to the Subscription Agreements are intended to be exempt
from registration under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), pursuant to Section 4(2) thereof
and Rule 506 of Regulation D (&ldquo;Regulation D&rdquo;) as promulgated by the United States Securities and Exchange Commission
(&ldquo;Commission&rdquo;) under the Securities Act, as the Shares were sold to accredited investors and were not sold through
any general solicitation or advertisement. The shares sold by the Company have not been registered under the Securities Act of
1933 and may not be offered or sold in the United States absent such registration or an available exemption from registration.</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Item 9.01 Financial Statements and
Exhibits.</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; font: 11pt/115% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financial statements of business acquired. None.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; font: 11pt/115% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pro forma financial information. None.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; font: 11pt/115% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shell company transactions. Not applicable.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; font: 11pt/115% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibits. None.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt 3in"><B>DigiPath, Inc.</B></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Date: May 14, 2014</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">By: <U>/s/ David Williams </U></P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">David Williams</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</P>

<P STYLE="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "digpform8k140514.htm", "description": "DIGIPATH, INC. FORM 8-K", "secsgml_size_bytes": 13203}]
{"company-data": {"conformed-name": "DigiPath,Inc.", "cik": "0001502966", "assigned-sic": "8742", "irs-number": "273601979", "state-of-incorporation": "NV", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54239", "film-number": "14840800"}, "business-address": {"street1": "2360 CORPORATE CIR", "street2": "SUITE 400", "city": "HENDERSON", "state": "NV", "zip": "89074", "phone": "702-527-2060"}, "mail-address": {"street1": "2360 CORPORATE CIR", "street2": "SUITE 400", "city": "HENDERSON", "state": "NV", "zip": "89074"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
May 14, 2014
____________________________
DigiPath, Inc.
(Exact name of registrant as
specified in charter)
Nevada
(State or other Jurisdiction of
Incorporation or Organization)
000-54239
(Commission File Number)
27-3601979
(IRS Employer Identification
        No.)
28720 Roadside Drive, Suite 128
Agoura Hills,
        CA 91301
(Address of Principal Executive
        Offices and zip code)
(702) 527-2060
(Registrant's telephone
number, including area code)
(Former name or former address,
if changed since last report.)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12(b) under
the Exchange Act (17 CFR 240.14a-12(b))
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.02 Unregistered Sales of Equity
Securities.
On May 14, 2014,
DigiPath, Inc. (the "Company") completed a private placement offering to certain accredited investors ("Investors")
pursuant to which the Company sold an aggregate of 44,200,000 shares of the Company's common stock ("Shares")
resulting in gross proceeds of $2,210,000 to the Company. The Company intends to use proceeds of the offering for working capital
and to develop its new lines of business associated with the research, development, licensing and operation of botanical and nutra-pharmaceutical
products and services, including, without limitation, the licensing of brand name nutra-pharmaceutical products. These business
lines will supplement its existing digital pathology solutions business that continues to generate revenue. The Company has no
material relationship with any of the accredited investors participating in the private placement offering other than in respect
of the investments.
The issuance of
the shares of the Company's common stock to the Investors pursuant to the Subscription Agreements are intended to be exempt
from registration under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to Section 4(2) thereof
and Rule 506 of Regulation D ("Regulation D") as promulgated by the United States Securities and Exchange Commission
("Commission") under the Securities Act, as the Shares were sold to accredited investors and were not sold through
any general solicitation or advertisement. The shares sold by the Company have not been registered under the Securities Act of
1933 and may not be offered or sold in the United States absent such registration or an available exemption from registration.
Item 9.01 Financial Statements and
Exhibits.
(a)
Financial statements of business acquired. None.
(b)
Pro forma financial information. None.
(c)
Shell company transactions. Not applicable.
(d)
Exhibits. None.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
DigiPath, Inc.
Date: May 14, 2014
By:
/s/ David Williams
David Williams
Chief Financial Officer